0001042167-24-000042.txt : 20240524
0001042167-24-000042.hdr.sgml : 20240524
20240524185148
ACCESSION NUMBER: 0001042167-24-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STEINER MITCHELL SHUSTER
CENTRAL INDEX KEY: 0001276244
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13602
FILM NUMBER: 24985886
MAIL ADDRESS:
STREET 1: 175 TOYOTA PLAZA
STREET 2: 7TH FLOOR
CITY: MEMPHIS
STATE: TN
ZIP: 38103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERU INC.
CENTRAL INDEX KEY: 0000863894
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 391144397
STATE OF INCORPORATION: WI
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 2916 N. MIAMI AVENUE
STREET 2: SUITE 1000
CITY: MIAMI
STATE: FL
ZIP: 33127
BUSINESS PHONE: 3125959123
MAIL ADDRESS:
STREET 1: 2916 N. MIAMI AVENUE
STREET 2: SUITE 1000
CITY: MIAMI
STATE: FL
ZIP: 33127
FORMER COMPANY:
FORMER CONFORMED NAME: FEMALE HEALTH CO
DATE OF NAME CHANGE: 19960205
FORMER COMPANY:
FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-05-22
0
0000863894
VERU INC.
VERU
0001276244
STEINER MITCHELL SHUSTER
2916 NORTH MIAMI AVENUE
SUITE 1000
MIAMI
FL
33127
1
1
0
0
President and CEO
0
Common Stock
2024-05-22
4
S
0
6504
1.3866
D
7006388
D
Common Stock
2024-05-23
4
S
0
300
1.35
D
7006088
D
Common Stock
2024-05-24
4
S
0
63379
1.2323
D
6942709
D
Common Stock
144000
I
Footnote
Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 0.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,615,996 shares, and will continue to be the Company's second largest shareholder.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.38 to $1.40. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.22 to $1.27. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
/s/ Michele Greco, via Power of Attorney
2024-05-24